Skip to content
Get a Demo
Contact Us

Pharmaceutical & biotech content management built for faster MLR review

Vodori customers cut review cycles to a median of 6.9 days without compromising compliance.

Get a Demo View Platform Overview

Trusted by pharmaceutical & biotech companies worldwide

women talking - phram & biotech

Purpose-built for pharmaceutical and biotech content review

Generic content management systems and heavily configured legacy platforms are slow to evolve, especially as global governance, brand complexity, and CRM strategy shift under you. Vodori is a modern, validated alternative built to keep pace: organizations that use Vodori typically see a 50%+ reduction in job duration. Plus, you get that speed without compromising governance. Content routes to your SOPs automatically, feedback lives in one place, and our platform 21 CFR Part 11 and EU Annex 11 compliant.

 
 

One platform for the review, approval, and distribution of regulated pharma content

Fast content review
Compliance automation
Digital & social review
Turnkey content delivery
Process optimization
Highly rated support

Reduce review cycle times by up to 30% to 60%

Our solutions are designed to be incredibly easy to use. Your review team can log in, review, collaborate on, and approve content quickly to support product launches and respond to needs in the field.

21 CFR Part 11 and EU Annex 11 compliance, built in

Vodori  is GxP-validated and compliant with 21 CFR Part 11 and EU Annex 11. Audit trails, claims tracking, and version history are built in, bringing audit response down from days to hours. Health authority submission support prepares materials for FDA Form 2253 without manual rework. 

Review digital and social content in its native format

Reviewers see web pages, HTML, and video the way an audience will, rather than as flattened PDFs. The same applies across promotional, medical, and non-promotional materials, so nothing gets approved out of context. 

 

Deliver compliant, approved content to sales and MSLs

As content is reviewed, approved, modified, or expired it is automatically updated in the digital asset management module or your downstream system of choice. This ensures compliant content usage based on user permissions–such as region, product, role, or disease state.

Optimize processes with data

Leverage process KPIs like average review time, circulations, and reasons for recirculation to make informed decisions about your people, processes, and technology. Vodori also publishes annual promotional review benchmarks, so you can measure your own cycle times against industry data. We will be there to help you dissect and apply insights every step of the way. 

Backed by a team of experts

Every Vodori customer receives 24/7/365 end user support and access to our Customer Success Team to ensure your success with our software. We’ll share best practices, provide process consultation, and work with you to make modifications needed as your business grows and changes.

“My experience working with Vodori felt like a real partnership. Vodori is responsive and really understands our needs.”

Associate Director Sales and Marketing, US pharmaceutical company

Read Reviews

Which content systems are actually built for regulated workflows?

Vodori delivers the same core MLR capabilities regulated teams rely on — parallel and sequential review, version control, claims management, audit support, and 21 CFR Part 11 eSignature — with none of the lock-in. The platform is built on an open architecture that connects cleanly with your existing CRM, DAM, and publishing tools, including native alignment with Salesforce Agentforce Life Sciences. So you get like-for-like functionality without being tied to a closed ecosystem. See a more detailed comparison to Veeva PromoMats.

Scroll to the right on the table below to see how Vodori compares to the competition.

FEATURES

Vodori Veeva Vault Box Sharepoint Email
Parallel & sequential review
Version control
Claims management Learn more
Audit support
21 CFR Pt 11 eSignature
Digital content review
Video support

IMPLEMENTATION

Vodori Veeva Vault Box Sharepoint Email
Guaranteed acceptance of configured system
Integrations included (SSO, CRM)
Added costs

ONGOING OPERATIONS

Vodori Veeva Vault Box Sharepoint Email
Validated, quarterly releases
Unlimited configuration changes (no cost)
Unlimited training (no cost)
24x7 user support (email, online chat)
Added costs

Frequently Asked Questions

How can life sciences marketing teams cut promotional review time in half?

Marketing teams shorten review cycles by replacing clunky, legacy software with an AI-powered, validated MLR platform that is easy to use, automatically routes content according to your SOPs, consolidates feedback in one place, and is 21 CFR Part 11 and EU Annex 11 compliant. Vodori customers reduce review cycle times by up to 30% to 60% while improving audit readiness. Based on data found in the 2025 State of Promotional Review Benchmarks Report, pharma companies using Vodori are able to review content in 6.7 days on average.

Which content review platforms handle social media and digital content review for pharma?

Pharma teams need a platform that reviews digital and social content in its native format, not flattened PDFs, so reviewers see what audiences will see and avoid compliance risk. Vodori supports review of promotional, medical, and non-promotional materials across formats, including web pages, HTML, and videos.

Which MLR platforms are 21 CFR Part 11 compliant?

Vodori is 21 CFR Part 11 and EU Annex 11 compliant, with built-in audit trails, claims tracking, and version history. It is also GxP-validated and inspection-tested, and its audit trails are designed to cut audit response time from days to hours.

Which content review tools support FDA Form 2253 submission prep?

Vodori provides health authority submission support that includes preparing materials for FDA Form 2253 submissions. It keeps each asset connected to its approved claims, references, and full review history, so the documentation needed for submission is assembled without manual rework, backed by audit-ready records. With the Vodori platform, you can also control content release until health authority submissions are completed, preventing your organization from unnecessary compliance risk.

What document management systems are built for regulated life sciences workflows?

Generic document management systems store files; systems built for regulated life sciences support the review, approval, and audit controls regulatory bodies expect. Vodori is purpose-built for MLR, with role-based permissions, audit trails, version control, and health authority submission support. It is a cloud-based, GxP-validated platform that connects content, claims, references, and approvals in one system of record and integrates seamlessly with existing DAMs, CRMs, and publishing tools.

How long should an MLR review cycle take in pharma?

Per Vodori's 2025 State of Promotional Review Benchmarks Report, pharma promotional review takes about 6.7 days on average and 3.9 days at the median. Across all industries, review duration averages 7.6 days. The full job, from preparation through final approval, averages 14.8 days across industries (median 6.9). Teams that continuously optimize consistently land at the faster end.

Ready to see what Vodori can do for you?

Let our Sales team walk you through a live, personalized 30 minute demonstration.

Get a Demo